Float Short %

2.29

Margin Of Safety %

Put/Call OI Ratio

0.07

EPS Next Q Diff

-0.96

EPS Last/This Y

0.8

EPS This/Next Y

1.2

Price

10.29

Target Price

Analyst Recom

4.33

Performance Q

-2.17

Relative Volume

1.2

Beta

0.68

Ticker: AMRN

22 items of 1

Date	Symbol	Last	P/C OI	P/C Vol	Total OI
2025-04-14	AMRN	9.445	0.05	0.50	15272
2025-04-15	AMRN	9.81	0.05	0.01	15081
2025-04-16	AMRN	9.33	0.05	0.07	15151
2025-04-17	AMRN	9.18	0.05	0.03	15281
2025-04-18	AMRN	9.11	0.05	0.03	15281
2025-04-21	AMRN	9.5	0.03	0.14	13686
2025-04-22	AMRN	10.4	0.03	0.68	13743
2025-04-23	AMRN	10.31	0.04	0.20	14043
2025-04-24	AMRN	11.13	0.04	0.17	14091
2025-04-25	AMRN	10.43	0.041087878344787	0.26315789473684	14240
2025-04-28	AMRN	10.32	0.04266199137994	0.7248322147651	14273
2025-04-29	AMRN	10.4	0.06	0.94	14776
2025-04-30	AMRN	10.76	0.07	0.00	15183
2025-05-01	AMRN	10.99	0.07	0.02	15197
2025-05-02	AMRN	10.99	0.07	2.37	15261
2025-05-05	AMRN	10.6	0.08	0.25	15379
2025-05-06	AMRN	10.31	0.08	0.46	15447
2025-05-07	AMRN	10.23	0.08	0.37	15788
2025-05-08	AMRN	10.72	0.08	0.12	15906
2025-05-09	AMRN	10.36	0.08	0.02	16175
2025-05-12	AMRN	10.45	0.08	8.55	16331
2025-05-13	AMRN	10.29	0.07	6.00	16241
Date	Symbol	Last	P/C OI	P/C Vol	Total OI

22 items 1 of 1

22 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-04-14	AMRN	9.47	-100.0	-	-3.20
2025-04-15	AMRN	9.81	-100.0	-	-3.20
2025-04-16	AMRN	9.33	-100.0	-	-3.20
2025-04-17	AMRN	9.11	-100.0	-	-3.20
2025-04-18	AMRN	9.11	-100.0	-	-3.20
2025-04-21	AMRN	9.51	-100.0	-	-3.20
2025-04-22	AMRN	10.46	-100.0	-	-3.20
2025-04-23	AMRN	10.36	-100.0	-	-3.20
2025-04-24	AMRN	11.18	-100.0	-	-3.20
2025-04-25	AMRN	10.43	-100.0	-	-3.20
2025-04-28	AMRN	10.32	-100.0	-	-3.20
2025-04-29	AMRN	10.33	-100.0	-	-3.20
2025-04-30	AMRN	10.78	-100.0	-	-3.20
2025-05-01	AMRN	10.98	-100.0	-	-3.20
2025-05-02	AMRN	10.91	-100.0	-	-3.20
2025-05-05	AMRN	10.61	-100.0	-	-3.20
2025-05-06	AMRN	10.26	-100.0	-	-3.20
2025-05-07	AMRN	10.18	-100.0	-	-3.20
2025-05-08	AMRN	10.72	-100.0	-	-3.20
2025-05-09	AMRN	10.40	-100.0	-	-3.20
2025-05-12	AMRN	10.42	-100.0	-	-3.20
2025-05-13	AMRN	10.29	-400.0	-	-3.20
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

22 items 1 of 1

22 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-04-14	AMRN	0.00	0	0.15
2025-04-15	AMRN	0.00	0	0
2025-04-16	AMRN	0	0	0
2025-04-17	AMRN	0	0	0.15
2025-04-18	AMRN	0.00	0	0.15
2025-04-21	AMRN	0.00	0	2.92
2025-04-22	AMRN	0.00	0	2.92
2025-04-23	AMRN	0.00	0	2.92
2025-04-24	AMRN	0.00	0	2.92
2025-04-25	AMRN	0.00	0	2.92
2025-04-28	AMRN	0.00	0	3.05
2025-04-29	AMRN	0.00	0	3.05
2025-04-30	AMRN	0.00	0	3.05
2025-05-01	AMRN	0.00	0	3.05
2025-05-02	AMRN	0.00	0	3.05
2025-05-05	AMRN	0.00	0	3.05
2025-05-06	AMRN	0.00	0	3.05
2025-05-07	AMRN	0.00	0	3.05
2025-05-08	AMRN	0.00	0	3.05
2025-05-09	AMRN	0.00	0	3.05
2025-05-12	AMRN	0.00	49.91	2.29
2025-05-13	AMRN	0.00	49.91	2.29
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

22 items 1 of 1

Last Quarter Act. EPS

-0.04

Avg. EPS Est. Current Quarter

-0.6

Avg. EPS Est. Next Quarter

-1

Insider Transactions

Institutional Transactions

49.91

Beta

0.68

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

94.4

Max Drawdown 5-Year %

-95.5

Target Price

P/E

Forward P/E

PEG

P/S

0.99

P/B

0.45

P/Free Cash Flow

EPS

-4.27

Average EPS Est. Cur. Y

-3.2

EPS Next Y. (Est.)

-2

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-40.99

Relative Volume

1.2

Return on Equity vs Sector %

-42.2

Return on Equity vs Industry %

-50.5

EPS 1 7Days Diff

1.2

EPS 1 30Days Diff

1.2

EBIT Estimation

Amarin Corporation plc

Sector: Healthcare

Industry: Drug Manufacturers - General

Employees: 275

Amarin Corporation plc, a pharmaceutical company, engages in the commercialization and development of therapeutics for the treatment of cardiovascular diseases in the United States, Europe, and internationally. The company offers VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. It sells its products principally through wholesalers, selected regional wholesalers, and specialty pharmacy providers. The company has a collaboration with Mochida Pharmaceutical Co., Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa, the omega-3 acid, EPA. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin 2, Ireland.

stock quote shares AMRN – Amarin Corp ADR Stock Price stock today

news today AMRN – Amarin Corp ADR stock forecast ,stock prediction 2023 2024 2025

marketwatch AMRN – Amarin Corp ADR yahoo finance google finance

stock history AMRN – Amarin Corp ADR invest stock market

stock prices AMRN premarket after hours

ticker AMRN fair value insiders trading

Investment involves risk. As a general rule, you should only trade in financial products that you are familiar with and understand the risk associated with them. The risk warning described in each financial product below is not exhaustive, you should carefully consider your investment experience, financial situation, investment objective, risk tolerance level and consult your independent financial adviser as to the suitability of your situation prior making any investment.

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: AMRN

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Get Started

About

Last Quarter Act. EPS

Average EPS Est. Cur. Y